MUFG Securities EMEA plc boosted its position in HCA Healthcare Inc (NYSE:HCA) by 230.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,204 shares of the company’s stock after buying an additional 16,887 shares during the period. MUFG Securities EMEA plc’s holdings in HCA Healthcare were worth $3,012,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of the stock. Benjamin F. Edwards & Company Inc. bought a new stake in HCA Healthcare during the 4th quarter worth approximately $25,000. Moody National Bank Trust Division bought a new stake in HCA Healthcare during the 4th quarter worth approximately $27,000. Doyle Wealth Management bought a new stake in HCA Healthcare during the 4th quarter worth approximately $31,000. Trust Co. of Vermont increased its holdings in HCA Healthcare by 165.3% during the 4th quarter. Trust Co. of Vermont now owns 329 shares of the company’s stock worth $41,000 after purchasing an additional 205 shares in the last quarter. Finally, Csenge Advisory Group bought a new stake in HCA Healthcare during the 3rd quarter worth approximately $48,000. 70.29% of the stock is owned by institutional investors and hedge funds.

A number of analysts have commented on the company. Zacks Investment Research lowered HCA Healthcare from a “buy” rating to a “hold” rating in a report on Tuesday, November 20th. Oppenheimer boosted their price objective on HCA Healthcare from $142.00 to $150.00 and gave the stock an “outperform” rating in a report on Wednesday, January 30th. Stephens assumed coverage on HCA Healthcare in a report on Monday, January 14th. They set an “overweight” rating and a $143.00 price objective for the company. ValuEngine lowered HCA Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, March 6th. Finally, Deutsche Bank assumed coverage on HCA Healthcare in a report on Thursday, January 3rd. They set a “buy” rating and a $140.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and seventeen have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $148.43.

HCA stock opened at $132.35 on Friday. The company has a market capitalization of $45.35 billion, a PE ratio of 13.55, a price-to-earnings-growth ratio of 1.07 and a beta of 0.80. HCA Healthcare Inc has a 12-month low of $93.03 and a 12-month high of $147.42.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, January 29th. The company reported $2.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.59 by $0.40. The company had revenue of $12.27 billion during the quarter, compared to analyst estimates of $12.10 billion. HCA Healthcare had a negative return on equity of 91.25% and a net margin of 8.11%. HCA Healthcare’s quarterly revenue was up 6.2% on a year-over-year basis. During the same period in the prior year, the company posted $2.12 earnings per share. On average, analysts anticipate that HCA Healthcare Inc will post 10.03 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 29th. Stockholders of record on Friday, March 1st will be issued a $0.40 dividend. The ex-dividend date of this dividend is Thursday, February 28th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.35. This represents a $1.60 annualized dividend and a dividend yield of 1.21%. HCA Healthcare’s dividend payout ratio is currently 16.38%.

In other news, CFO Bill B. Rutherford sold 37,500 shares of the company’s stock in a transaction that occurred on Tuesday, February 12th. The stock was sold at an average price of $139.65, for a total value of $5,236,875.00. Following the completion of the transaction, the chief financial officer now directly owns 58,972 shares of the company’s stock, valued at $8,235,439.80. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP J William Morrow sold 263 shares of the company’s stock in a transaction that occurred on Thursday, February 7th. The shares were sold at an average price of $140.60, for a total value of $36,977.80. Following the completion of the transaction, the senior vice president now directly owns 5,922 shares of the company’s stock, valued at $832,633.20. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 78,476 shares of company stock valued at $10,940,008. 2.80% of the stock is currently owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: This article was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this article on another site, it was illegally stolen and reposted in violation of US and international copyright law. The original version of this article can be read at https://www.watchlistnews.com/hca-healthcare-inc-hca-shares-bought-by-mufg-securities-emea-plc/2895869.html.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

See Also: Dow Jones Industrial Average (DJIA)

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.